Crane NXT (CXT) stock is a sell: weak earnings quality, high leverage, shrinking DTT margins, and acquisition dilution.

Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...

On June 9, 2026, the New York State Department of Financial Services (“NYDFS” or the “Department”) announced a proposed regulation, Proposed New ...

Below is a list and photo gallery of buildings, signs, hotels and golf course resorts that have Trump's face or name − as ...